Acta Pharmaceutica · 2015 · 13 citations · 23 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryMolecular OncologyMetastatic Breast CancerPharmacodynamics Of Anticancer AgentsAntiproliferative AgentsAntiproliferative Drug ActionCell Viability AssaysMedicinal HeterocyclesMetastatic Breast Cancer BiologyMetastatic Breast Cancer TreatmentPotency MeasurementThiazole Chemistry
The study highlights the current progress in the development of coumarin scaffolds for drug discovery as novel anticancer agents in metastatic breast cancer. Eight compounds, combining the coumarin core and five membered heterocycles (isoxazoles and thiazoles) in hydrazinyldiene- -chroman-2,4-diones, were characterized in terms of a potential antiproliferative effect on bone (SCP1833) and lung (SCP4175) metastatic breast cancer cell lines using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay. Cell viability was evaluated after 48 and 72 h of treatment and the 50 % inhibitory concentrations were determined. The results demonstrated dose- and time-dependent activity, with the most potent molecules having a thiazole moiety, without or with additional methyl group(s) attached to the carbon(s) at position(s) 5 and/or 4 in the thiazole ring. These molecules possessed significantly higher potency against both test cell lines compared to 4-hydroxycoumarin.
23
Genes that mediate breast cancer metastasis to lung
Andy J. Minn, Gaorav P. Gupta, Peter M. Siegel et al. · Nature · 2005 · 3K citations · Full text
A multigenic program mediating breast cancer metastasis to bone
Yibin Kang, Peter M. Siegel, Weiping Shu et al. · Cancer Cell · 2003 · 2.6K citations · Full text
Epidemiology and prognosis of breast cancer in young women.
Hussein Assi, Katia Khoury, Haifa Dbouk et al. · PubMed · 2013 · 306 citations · Full text
Medicine, Oncology, Breast Oncology +15